Amarin Corp Plc (AMRN)

[couldbebetter]

Crikker, At $6 billion in revenues the valuation may be 4-5 times
that amount, or $24-$30 billion. As to shares outstanding, I would
use 500 million as to be conservative. AMRN may do acquisitions,
raise additional cash for expansion purposes, and of course continue
to reward management. So stock price wise I think it would trade
for around $50-$60 a share. That would be a fantastic return of up
to around 200% from recent prices.

If anyone wants a good comparable stock I would look at ABBV. Why?
ABBV has the best selling drug in the world today which does about
$20 billion in annual revenues. ABBV sells at a PE of around 10 x
this years EPS and 9 X next years estimated EPS. The issue for
ABBV is that their patent protection will expire in the US in 2023,
but is a complex situation. At ABBV's peak price of around $125 it
was trading at about 6 x its revenues for that year. ABBV trades
at around 4 x revenues. My reason for mentioning ABBV is because
it is the closest example I can find of what AMRN may evolve
into based on a GIA scenario.